CIAM
CLPT icon

Caitong International Asset Management’s ClearPoint Neuro CLPT Stock Holding History

Caitong International Asset Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38
Closed -$520 – 2670
2025
Q4 		$520 Buy
+38
New +$704 ﹤0.01% 1466

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Caitong International Asset Management's CLPT Position: Q1 2026 in Review

Caitong International Asset Management sold out of ClearPoint Neuro (CLPT) in Q1 2026, closing a stake of 38 shares — an estimated $520 sold.

Caitong International Asset Management first reported a position in CLPT in Q4 2025 and held it in 1 quarter. The position peaked at $520 in Q4 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Caitong International Asset Management reported no remaining ClearPoint Neuro position as of Q1 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 38 ClearPoint Neuro shares in Q1 2026, an estimated $520.
  • Caitong International Asset Management first reported a position in ClearPoint Neuro in Q4 2025 and held it in 1 quarter.
  • Caitong International Asset Management's ClearPoint Neuro position peaked at $520 in Q4 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.